Lack of association between MTHFR C677T polymorphism and breast cancer risk in Ahvaz, west south-Iran

Authors

1 Department of Biochemistry, Faculty of Medicine, Hyperlipidemia Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

2 Department of Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

3 Department of Radiation and Clinical Oncology, Faculty of Medicine, Ahvaz Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Abstract

Background: Association between C677T polymorphism of the methylenetetrahydrofolate reductase (MTHFR), a key enzyme involved in folate metabolism and DNA methylation, and breast cancer risk are inconsistent. We investigated in a case-control study, possible effect of the common MTHFR C677T polymorphism on breast cancer risk in a sample of Iranian patients.
Materials and Methods: The study subjects comprised of 123 breast cancer cases and 110 cancer-free control, who were matched for age and body mass index (BMI). C677T genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay. Lipid profile was measured in all subjects by standard method.




Results: The genotypes distributions (CC, CT, and TT) were 55.3, 39, and 5.7% in breast cancer cases and 51.8, 44.5, and 3.6% in controls. Chi square analysis revealed that there was no significant association between breast cancer risk and MTHFR genotypes and alleles. Additionally, no significant association was observed between C677T genotypes and biochemistry parameters. A multinomial logistic regression model with MTHFR genotypes, lipid profiles, BMI and age as covariates revealed that there is no significant association between MTHFR genotypes and risk of breast cancer, but higher values of LDL and HDL significantly increase risk of breast cancer.
Conclusions: Our findings do not support the hypothesis that genetic variation in the MTHFR C677T polymorphism is implicated in the breast cancer risk in a sample of Iranian patients.

Keywords

1.
Kim YI. Folate and carcinogenesis: Evidence, mechanisms, and implications. J Nutr Biochem 1999;10:66-88.  Back to cited text no. 1
    
2.
Mason JB, Choi SW. Folate and carcinogenesis: Developing a unifying hypothesis. Enzyme Regul 2000;40:127-41.  Back to cited text no. 2
    
3.
Bailey LB, Gregory JF 3rd. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement. J Nutr 1999;129:919-22.  Back to cited text no. 3
    
4.
Choi SW, Mason JB. Folate and carcinogenesis: An integrated scheme. J Nutr 2000;130:129-32.  Back to cited text no. 4
    
5.
Robien K, Ulrich CM, Bigler J, Yasui Y, Gooley T, Bruemmer B, et al. Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia. Clin Cancer Res 2004;10:7592-8.  Back to cited text no. 5
    
6.
Fodinger M, Horl WH, Sunder-Plassmann G. Molecular biology of 5, 10-methylenetetrahydrofolate reductase. J Nephrol 2000;13:20-33.  Back to cited text no. 6
    
7.
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.  Back to cited text no. 7
    
8.
Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, et al. Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping and mutation identification. Nat Genet 1994;7:195-200.  Back to cited text no. 8
    
9.
Weisberg IS, Jacques PF, Selhub J, Bostom AG, Chen Z, Curtis ER, et al. The 1298A->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): In vitro expression and association with homocysteine. Atherosclerosis 2001;156:409-15.  Back to cited text no. 9
    
10.
Sohn KJ, Croxford R, Yates Z, Lucock M, Kim YI. Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemo sensitivity of colon and breast cancer cells to 5- fluorouracil and methotrexate. J Natl Cancer Inst 2004;96:134-44.  Back to cited text no. 10
    
11.
Thomas P, Fenech M. Methylenetetrahydrofolate reductase, common polymorphisms, and relation to disease. Vitam Horm 2008; 79: 375-392.  Back to cited text no. 11
    
12.
Chen J, Ma J, Stampfer MJ, Palomeque C, Selhub J, Hunter DJ. Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. Pharmacogen 2002;12:339-342.  Back to cited text no. 12
    
13.
Boccia S, Hung R, Ricciardi G, Gianfagna F, Ebert MP, Fang JY, et al. Metaand pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: A huge-GSEC review. Am J Epidemiol 2008;167:505-16.  Back to cited text no. 13
    
14.
Graziano F, Kawakami K, Ruzzo A, Watanabe G, Santini D, Pizzagalli F, et al. Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population. Int J Cancer 2006;118:628-32.  Back to cited text no. 14
    
15.
Esteller M, Garcia A, Martinez-Palones JM, Xercavins J, Reventos J. Germ line polymorphisms in cytochrome- P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis 1997;18:2307-11.  Back to cited text no. 15
    
16.
Siemianowicz K, Gminski J, Garczorz W, Slabiak N, Goss M, Machalski M, et al. Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms in patients with small cell and non-small cell lung cancer. Oncol Rep 2003;10:1341-4.  Back to cited text no. 16
    
17.
Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 1999;96:12810-5.  Back to cited text no. 17
    
18.
Sharp L, Little J, Schofield AC, Pavlidou E, Cotton SC, Miedzybrodzka Z, et al. Folate and breast cancer: The role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett 2002; 181:65-71.  Back to cited text no. 18
    
19.
Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, Watanabe M, et al. One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 2008;29:356-362.  Back to cited text no. 19
    
20.
Semenza JC, Delfino RJ, Ziogas A, Anton-Culver H. Breast cancer risk and methylenetetrahydrofolate reductase polymorphism. Breast Cancer Res Treat 2003;77:217-23.  Back to cited text no. 20
    
21.
Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, et al. The common 677C>T gene polymorphism of methylenetetrahydrofolatereductase gene is not associated with breast cancer risk. Breast Cancer Res Treat 2003;81:169-72.  Back to cited text no. 21
    
22.
Maruti SS, Ulrich CM, Jupe ER, White E. MTHFRC677T and postmenopausal breast cancer risk by intakes of one-carbon metabolism nutrients: A nested case-control study. Breast Cancer Res 2009;11: R91.  Back to cited text no. 22
    
23.
Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Hebert JR, et al. MTHFR polymorphisms, dietary folate intake, and breast cancer risk: Results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev 2004;13:190-6.  Back to cited text no. 23
    
24.
Forsti A, Angelini S, Festa F, Sanyal S, Zhang Z, Grzybowska E, et al. Single nucleotide polymorphisms in breast cancer. Oncol Rep 2004;11:917-22.  Back to cited text no. 24
    
25.
Lee SA, Kang D, Nishio H, Lee MJ, Kim DH, Han W, et al. Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women. Exp Mol Med 2004;36:116-21.  Back to cited text no. 25
    
26.
Grieu F, Powell B, Beilby J, Iacopetta B. Methylenetetrahydrofolate reductase and thymidylate synthasepolymorphisms are not associated with breast cancer risk or phenotype. Anticancer Res 2004;24:3215-9.  Back to cited text no. 26
    
27.
Lin WY, Chou YC, Wu MH, Huang HB, Jeng YL, Wu CC, et al. The MTHFR C677T polymorphism, estrogen exposure and breast cancer risk: A nested case-control study in Taiwan. Anticancer Res 2004;24:3863-8.  Back to cited text no. 27
    
28.
Le Marchand L, Haiman CA, Wilkens LR, Kolonel LN, Henderson BE. MTHFR polymorphisms, diet, HRT, and breast cancer risk: The multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2004;13:2071-7.  Back to cited text no. 28
    
29.
Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC, et al. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res 2005;65:1606-14.  Back to cited text no. 29
    
30.
Kalemi TG, Lambropoulos AF, Gueorguiev M, Chrisafi S, Papazisis KT, Kotsis A. The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece. Cancer Lett 2005;222:57-65.  Back to cited text no. 30
    
31.
Hekim N, Ergen A, Yaylim I, Yilmaz H, Zeybek U, Ozturk O, et al. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer. Cell Biochem Funct 2007;25:115-7.  Back to cited text no. 31
    
32.
Ericson U, Sonestedt E, Ivarsson MI, Gullberg B, Carlson J, Olsson H, Wirfält E. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort. Cancer Epidemiol Biomarkers Prev 2009;18:1101-10.  Back to cited text no. 32
    
33.
Justenhoven C, Hamann U, Pierl CB, Rabstein S, Pesch B, Harth V, et al. One-carbon metabolism and breast cancer risk: No association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol Biomarkers Prev 2005;14:3015-18.  Back to cited text no. 33
    
34.
Chou YC, Wu MH, Yu JC, Lee MS, Yang T, Shih HL, et al. Genetic polymorphisms of methylenetetrahydrofolate reductase gene, plasma folate levels, and breast cancer susceptibility: A case-control study in Taiwan. Carcinogenesis 2006;27:2295-300.  Back to cited text no. 34
    
35.
Jakubowska A, Gronwald J, Menkiszak J, Gorski B, HuzarskiT, Byrski T, et al. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks. Breast Cancer Res Treat 2007;104:299-308.  Back to cited text no. 35
    
36.
Mohammadzadeh G, Ghaffari MA, Bafandeh A, Hosseini SA. Association of serum soluble leptin receptor and leptin levels with breast cancer. J Res Med Sci 2014;19:433-8.  Back to cited text no. 36
[PUBMED]  Medknow Journal  
37.
Antoniadi T, Hatzis T, Kroupis C, Economou-Petersen E and Petersen MB. Prevalence of factor V leiden, prothrombin G20210A, and MTHFR C677T mutations in a Grece population of blood donors. Am J Hematol 1999;61:265-7.  Back to cited text no. 37
    
38.
Campbell IG, Baxter SW, Eccles DM and Choong DYH: Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res 2002;4:R14.  Back to cited text no. 38
    
39.
Piyathilake CJ, Macaluso M, Johanning, GL, Whiteside M, Heimburger DC and Giuliano A. Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Anticancer Res 2000;20:1751-7.  Back to cited text no. 39
    
40.
Goodman MT, Mc Duffie K, Hernandez B, Wilkens LR, Bertram CC, Killeen J, et al. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 2001;10:1275-80.  Back to cited text no. 40
    
41.
Gerhard DS, Nguyen LT, Zhang ZY, Borecki IB, Coleman BI, Rader JS. A relationship between methylenetetrahydrofolate reductase variants and the development of invasive cervical cancer. Gynecol Oncol 2003;90:560-65.  Back to cited text no. 41
    
42.
Keku T, Millikan R, Worley K, Winkel S, Eaton A, Biscocho L, et al. 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev 2002;11:1611-21.  Back to cited text no. 42
    
43.
Zhang J, Zotz RB, Li Y, Wang R, Kiel S, Schulz WA, et al. Methylenetetrahydrofolate reductase C677T polymorphism and predisposition towards esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. J Cancer Res Clin Oncol 2004;130:574-80.  Back to cited text no. 43
    
44.
Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, et al. MTHFRC677T polymorphism associated with breast cancer susceptibility: A meta-analysis involving 15,260 cases and 20,411 controls. Breast Cancer Res Treat 2010;123:549-55.  Back to cited text no. 44
    
45.
Qi X, Ma X, Yang X, Fan L, Zhang Y, Zhang F, et al. Methylenetetrahydrofolate reductase polymorphism and breast cancer risk: A meta-analysis from 41 studies with 16,480 cases and 22,388 controls. Breast Cancer Res Treat 2010;123:499-506.  Back to cited text no. 45